Analystreport

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) was downgraded by analysts at UBS Group AG to a "hold" rating. They now have a $18.00 price target on the stock.

SUCAMPO PHARMACEUTICALS  (SCMP) 
Last sucampo pharmaceuticals earnings: 11/1 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.sucampo.com